ProciseDx

ProciseDx is a healthcare technology company specializing in point of care diagnostic solutions. The company operates in the medical diagnostics market, providing healthcare professionals with the ability to obtain lab-quality results in real-time, directly in their offices. ProciseDx's platform is optimized for quantitative immunoassays, which are tests that measure the presence or concentration of a substance in a solution using an antibody or antigen. This allows for immediate clinical decisions during patient appointments or pharmacy visits, significantly improving the efficiency of patient care.

The company's primary clients include gastroenterologists and other healthcare providers who require rapid and accurate diagnostic results to monitor therapeutic treatments, particularly for inflammatory bowel diseases. ProciseDx leverages proven technology and patented chemistry to deliver diagnostic answers from a finger prick sample in less than 5 minutes. This quick turnaround time enables healthcare professionals to make informed treatment decisions on the spot, enhancing patient outcomes.

ProciseDx's business model revolves around the sale of its diagnostic platform and assays, generating revenue through the sale of these products to healthcare providers. The company also benefits from recurring revenue through the continuous need for its diagnostic tests.

Keywords: point of care, diagnostic solutions, immunoassays, lab-quality results, healthcare technology, gastroenterologists, inflammatory bowel diseases, rapid diagnostics, therapeutic monitoring, patented chemistry.